Your Job & Career
Best Newsletters for Doctors & Medical Professionals
Keep up with clinical medicine and the system around it, from research and guidelines to reimbursement, workforce and burnout, drug approvals, and the AI tools now sitting between you and the patient. Written for physicians, nurses, and clinical leaders.
The best newsletters for doctors & medical professionals right now are Axios VitalsSTAT Morning Rounds, and Healthcare Dive Daily Dive. Below is our full 10-newsletter reading list for the role, each one verified against its live signup page, with why it earns a slot, and available as one five-minute daily audio briefing.
The bundle at a glance
| # | Newsletter | Cadence | Cost | Readers | Best for |
|---|---|---|---|---|---|
| 1 | Axios Vitals | Daily | Free | Busy readers who want the day's biggest health policy and industry news in a few fast bullets, with a Washington-and-industry angle. | |
| 2 | STAT Morning Rounds | Daily | Free | Insiders who want the first, best-sourced read of the day on health, medicine, and life sciences from STAT's newsroom. | |
| 3 | Healthcare Dive Daily Dive | Daily (weekdays) | Free | 170k readers | Non-insiders and professionals alike who want a free, digestible weekday briefing on hospitals, payers, policy, and healthcare dealmaking. |
| 4 | Inside Medicine | 3-5x weekly | Free | 88k readers | Readers who want frontline emergency-medicine perspective paired with rigorous, methods-literate reads of new medical and public-health data. |
| 5 | Becker's Hospital Review | Daily for Hospital Review; specialty lists 1–5× weekly | Free | 1M readers | Hospital executives and vendors who need high-volume daily coverage of health system M&A, leadership moves, and operations in punchy briefs. |
| 6 | KFF Health News Morning Briefing | Daily (weekdays) | Free | Health-policy professionals who want each weekday's Medicare, Medicaid, and drug-pricing coverage summarized from more than 50 sources in one nonprofit-produced email. | |
| 7 | BioPharma Dive Daily Dive | Weekdays | Free | 206k readers | Biopharma professionals who want a free weekday briefing on clinical trial readouts, FDA actions, and dealmaking written for people inside the industry. |
| 8 | Fierce Pharma / Fierce Biotech | Daily | Free | Industry professionals who want comprehensive, high-volume daily coverage of pharma marketing, manufacturing, and biotech financing every weekday morning. | |
| 9 | The Readout | Weekdays | Free | ||
| 10 | GEN Daily | Daily | Free |
Why guidelines change quietly and nobody sends a memo
A general news app tells you a study made headlines. It rarely tells you the effect size was tiny, the trial was underpowered, or the guideline quietly changed. Newsletters written by practicing physicians and epidemiologists give you the clinical context a consumer-health feed strips out, and they surface the drug alerts and infectious-disease trends you need before a patient asks. That signal-to-noise is the whole point.
Medicine keeps moving while you are seeing patients
You finished training years ago, but the literature never stops moving. Between clinic, rounds, and charting, keeping current on new trials, drug updates, and shifting guidelines competes with everything else in the day. These newsletters are how working physicians and clinicians stay on top of what changed in medicine without reading every journal cover to cover.
How to practise at the front of the evidence, not behind it
This is a general-medicine list built for clinicians who are already in practice, not a specialty reading list and not a study aid for boards. It pairs fast newsroom briefings with physician-written analysis that stress-tests the evidence, so you get both the headline and whether it actually holds up. Every pick is written by or for people who see patients or read the primary literature for a living.
AI moved from your notes into the decision about what gets paid for
Physician adoption went from novelty to default in three years. The American Medical Association's 2026 survey of 1,692 physicians, fielded in January and February, found 81 percent now use AI in practice, against 38 percent in 2023, with the fastest growth in summarising research and standards of care, up from 13 percent in 2024 to 39 percent. Ambient documentation is the headline use: the note gets drafted from the consultation while you have the consultation. Most physicians welcome it, and 76 percent say AI improves their ability to care for patients.
Read the restShow less
Two findings from the same survey sit underneath the enthusiasm. Eighty-eight percent worry about losing skills, and 92 percent want more training on AI while 27 percent have had none from any source. The regulatory position is stranger than most clinicians realise: the FDA has authorised more than 1,600 AI-enabled medical devices, and as of early 2026 not one of them was generative. The large language models now in daily clinical use sit outside the device clearance regime entirely, which puts the judgment about when to trust them squarely on the clinician.
Then in January 2026 AI arrived on the other side of the table. Medicare's WISeR model began using machine-assisted review for prior authorisation and pre-payment decisions on selected Part B services across six states, with licensed clinicians retaining final authority to deny. A bill to ban AI denials in Medicare was introduced weeks before it launched. Whatever you think of it, the documentation and appeal craft that gets a patient their treatment is now partly a contest with a model, and knowing how it works is clinical practice rather than administration.
The right mix for this role
We drew your bundle across 2 of our news categories, weighted for what actually moves the needle in this job:
- 6Healthcare & Medicine →The spine of the bundle: daily clinical news, evidence appraisal, drug and policy coverage, and practical epidemiology, all from the catalog's core medical category.
- 4Biotech & Pharma →The pipeline, from trial readout to approval, before it reaches your formulary.
The newsletters every practicing physician should be reading
- 1
Why doctors & medical professionals read itAxios's smart-brevity daily on the business and policy of American healthcare. It covers the payer, policy and system decisions that shape how medicine actually gets practiced, in a few bullets.
Axios Vitals applies the smart-brevity format to healthcare: the day's biggest health policy and industry stories in a few bullets each, with a Washington-and-industry angle. It is built for speed. Health care news in three minutes.
- 2
Why doctors & medical professionals read itSTAT's free weekday briefing is the insider's first read on health, medicine, and life sciences, reported by one of the best newsrooms on the beat. For a practicing clinician it is the fastest way to catch drug approvals, trial results, and policy shifts before they reach the exam room.
Morning Rounds is STAT's flagship morning email: health, medicine, and life-sciences news reported by the best newsroom on the beat, with real sourcing and a fast news sense. It is the insider's first read of the day. Free, unlike much of STAT's site.
- 3
Why doctors & medical professionals read itIndustry Dive's weekday rundown of hospital, payer and health-policy news. The trade read for the business side of the institution you work inside.
Healthcare Dive is Industry Dive's free weekday briefing on the business of healthcare: hospitals, payers, policy, and the deals between them. Its advertising page claims 170,000 newsletter subscribers. A trade read that non-insiders can follow.
- 4
Why doctors & medical professionals read itEmergency physician Jeremy Faust writes between shifts, pairing what he sees in the ED with rigorous, methods-literate reads of new medical and public-health data. For a practicing clinician it is frontline perspective plus the statistical literacy to tell a real finding from a noisy one.
Jeremy Faust, an emergency physician, writes Inside Medicine between shifts, pairing what he sees in the emergency department with rigorous reads of new medical and public-health data. Main content stays free, with a paid tier for extras. Frontline perspective plus real methods literacy, for over 88,000 subscribers.
- 5
Why doctors & medical professionals read itExecutive-level intelligence on hospital operations, finance, leadership and regulation. It is how a clinician finds out what administration is being told.
The industry tip sheet for hospital executives, delivering high-volume daily coverage of health system M&A, leadership changes, finance, and operations in punchy list-driven briefs. The voice is fast trade journalism, breadth over depth. Indispensable for anyone working in or selling to hospitals; overkill for casual health readers. Multiple specialty editions (CFO, Health IT, Clinical) are available from the same signup.
- 6
Why doctors & medical professionals read itKFF Health News distills each weekday's health policy and medicine headlines from more than fifty sources into one briefing. The broadest single sweep of the beat, and free.
KFF Health News' Morning Briefing summarizes each weekday's health policy and medicine coverage from more than 50 news sources, produced by an independent nonprofit newsroom. It is the daily read of health-policy professionals. Medicare, Medicaid, drug prices, and the politics around them, in one email.
- 7
Why doctors & medical professionals read itIndustry Dive's weekday briefing on clinical trials, FDA actions and dealmaking. It tracks a drug from readout to approval well before it reaches your formulary.
BioPharma Dive is Industry Dive's free weekday briefing on biotech and pharma: clinical trial readouts, FDA actions, and dealmaking, written for people inside the industry. Its advertising page claims 206,000 newsletter subscribers. The accessible end of the biopharma trade press.
- 8
Why doctors & medical professionals read itThe long-running flagship daily on pharma and biotech industry news. It covers the companies and approvals that decide what you end up prescribing.
Fierce Pharma and Fierce Biotech are the long-running flagship dailies of the drug-industry trade press, covering pharma marketing, manufacturing, clinical results, and biotech financing each weekday morning. High volume and comprehensive. The default inbox presence for industry professionals.
- 9
Why doctors & medical professionals read itSTAT's weekday morning newsletter on the science, politics and money driving biotech. The best-sourced read on the beat, from a newsroom clinicians already trust.
The Readout lands every weekday morning with a rundown of biotech news: clinical readouts, FDA decisions, deals, and market moves, linking to STAT's reporting. The signup page currently credits reporters Meghana Keshavan and Elaine Chen. The newsletter itself is free, though some linked stories sit behind the STAT+ paywall.
- 10
Why doctors & medical professionals read itDaily coverage of biotech research, drug development and the science behind it. Closer to the bench than the business, which is the half the trade press skips.
GEN Daily delivers headlines from GEN's newsroom, spanning bench research, tools and techniques, and biopharma business developments. It is free with a GEN account, which also unlocks the digital magazine; a separate paid GEN Edge tier carries premium analysis. GEN is the flagship publication of scientific publisher Mary Ann Liebert, Inc.
Miss these and you learn about the new drug interaction from a patient, not before. You hear a guideline changed after you have already counseled someone the old way, and you catch the RSV or measles surge in your area a week late. The doctors who read these are the ones who never get caught flat-footed in the exam room.
Start the Doctors & Medical Professionals bundle →Read by millions · one briefing · free to start
Questions
- Who is this list for?
- This list is for practicing physicians and clinicians who are already out of training and need to stay current on clinical news, new research, and public health. It centers day-to-day practice rather than exam prep or a single specialty, so if you see patients or read the literature for a living, it is built for you.
- How is this different from your medical students list?
- Our medical students and doctors list centers training, board prep, and building foundational knowledge. This page is for clinicians already in practice, so it leans on fast clinical news, evidence appraisal, and drug and public-health updates rather than study material.
- Do I need to pay for all of these newsletters?
- No. Most of the picks are free, including STAT Morning Rounds, Axios Vitals, the KFF Health News Morning Briefing, Healthcare Dive and Inside Medicine. A few have paid tiers for extras, but you can build a strong clinical reading habit without paying for any of them.
- How does Hark News turn these into audio?
- You forward the newsletters you want to your private Hark News address, and Hark News turns them into a single daily audio briefing of about five minutes. Instead of a crowded inbox, you get one narrated rundown you can hear on the commute or between patients.
- Will this cover my specialty?
- This is a general-medicine bundle built for broad clinical awareness, not a specialty-specific reading list. JAMA's alerts let you subscribe to specialty journals like JAMA Neurology or JAMA Internal Medicine, so you can layer your own field on top of the general foundation these picks provide.
- Can I add my own newsletters or drop ones I do not want?
- Yes. The bundle is a starting point, and you can add any newsletter you already subscribe to or mute the ones you do not want. Hark News briefs you on whatever lands in your forwarding address, so the mix is yours to shape.
- What is the best free daily medical newsletter for doctors?
- STAT Morning Rounds is the strongest free daily pick: a weekday rundown of health, medicine, and life-sciences news from one of the best newsrooms on the beat. If you want physician-written analysis alongside it, Jeremy Faust's Inside Medicine is also free, and Hark News can turn both into one short audio briefing.